Icon PLC's stock plummeted 5.22% during intraday trading on Friday, marking a significant decline for the clinical research organization.
The sharp drop followed the company's announcement that it is delaying its annual Form 20-F filing for the fiscal year ended December 31, 2025. The audit committee has concluded that previously issued audited financial statements for 2023 and 2024 should no longer be relied upon, requiring a restatement of those periods.
ICON indicated it plans to include the restated financial information in its 2025 Form 20-F but cannot yet quantify the impact of the restatement work on its 2025 results. This development creates uncertainty around the company's financial reporting and raises concerns among investors about the reliability of its historical financial statements.